发明名称 Aerosolized fosfomycin/aminoglycoside combination for the treatment of cystic fibrosis
摘要 <p>A fosfomycin plus tobramycin combination formulation for delivery by acrosolization is described. The concentrated fosfomycin tobramycin combination formulation containing an efficacious amount of fosfoinycin plus tobramycin is able to inhibit susceptible bacteria. Fosfomycin and tobramycin are formulated separately in a dual ampoule such that when reconstituted, the pH is between 4.5 and 8.0 or as a dry powder. The method for treatment of respiratory tract infections by a formulation delivered as an aerosol having mass medium average diameter predominantly between 1 to 5 [mu], produced by a jet or ultrasonic nebulizer (or equivalent) or dry powder inhaler.</p>
申请公布号 IL225529(A) 申请公布日期 2014.08.31
申请号 IL20130225529 申请日期 2013.04.02
申请人 GILEAD SCIENCES INC. 发明人
分类号 A61K;A61K9/00;A61K45/06;C07F 主分类号 A61K
代理机构 代理人
主权项
地址